These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

849 related items for PubMed ID: 25821094

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Exploring relationships between joint hypermobility and neurodevelopment in children (4-13 years) with hereditary connective tissue disorders and developmental coordination disorder.
    Piedimonte C, Penge R, Morlino S, Sperduti I, Terzani A, Giannini MT, Colombi M, Grammatico P, Cardona F, Castori M.
    Am J Med Genet B Neuropsychiatr Genet; 2018 Sep; 177(6):546-556. PubMed ID: 30070022
    [Abstract] [Full Text] [Related]

  • 45. The multifaceted and complex hypermobility syndrome (a.k.a. Ehlers-Danlos Syndrome Hypermobility Type): evaluation and management through a rehabilitative approach.
    Celletti C, Camerota F.
    Clin Ter; 2013 Sep; 164(4):e325-35. PubMed ID: 24045532
    [Abstract] [Full Text] [Related]

  • 46. Surgical Management of Shoulder and Knee Instability in Patients with Ehlers-Danlos Syndrome: Joint Hypermobility Syndrome.
    Homere A, Bolia IK, Juhan T, Weber AE, Hatch GF.
    Clin Orthop Surg; 2020 Sep; 12(3):279-285. PubMed ID: 32904109
    [Abstract] [Full Text] [Related]

  • 47. Symptomatic Joint Hypermobility: The Hypermobile Type of Ehlers-Danlos Syndrome and the Hypermobility Spectrum Disorders.
    Tinkle BT, Levy HP.
    Med Clin North Am; 2019 Nov; 103(6):1021-1033. PubMed ID: 31582002
    [Abstract] [Full Text] [Related]

  • 48. A humanisation approach for the management of Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-Hypermobility Type (JHS/EDS-HT).
    Clark CJ, Knight I.
    Int J Qual Stud Health Well-being; 2017 Dec; 12(1):1371993. PubMed ID: 28866967
    [Abstract] [Full Text] [Related]

  • 49. Subjective health complaints and illness perception amongst adults with Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-HypermobilityType - a cross-sectional study.
    Hope L, Juul-Kristensen B, Løvaas H, Løvvik C, Maeland S.
    Disabil Rehabil; 2019 Feb; 41(3):333-340. PubMed ID: 29041819
    [Abstract] [Full Text] [Related]

  • 50. Joint Hypermobility Syndrome and Membrane Proteins: A Comprehensive Review.
    Pliego-Arreaga R, Cervantes-Montelongo JA, Silva-Martínez GA, Tristán-Flores FE, Pantoja-Hernández MA, Maldonado-Coronado JR.
    Biomolecules; 2024 Apr 12; 14(4):. PubMed ID: 38672488
    [Abstract] [Full Text] [Related]

  • 51. Living with joint hypermobility syndrome: patient experiences of diagnosis, referral and self-care.
    Terry RH, Palmer ST, Rimes KA, Clark CJ, Simmonds JV, Horwood JP.
    Fam Pract; 2015 Jun 12; 32(3):354-8. PubMed ID: 25911504
    [Abstract] [Full Text] [Related]

  • 52. Quality of life prediction in children with joint hypermobility syndrome.
    Pacey V, Tofts L, Adams RD, Munns CF, Nicholson LL.
    J Paediatr Child Health; 2015 Jul 12; 51(7):689-95. PubMed ID: 25622801
    [Abstract] [Full Text] [Related]

  • 53. Relationship Between Psychological Trauma and Irritable Bowel Syndrome and Functional Dyspepsia in a Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome Patient Population.
    Silvernale C, Garcia-Fischer I, Staller K.
    Dig Dis Sci; 2024 Mar 12; 69(3):870-875. PubMed ID: 38112834
    [Abstract] [Full Text] [Related]

  • 54. Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.
    Micale L, Fusco C, Castori M.
    Adv Exp Med Biol; 2021 Mar 12; 1348():207-233. PubMed ID: 34807421
    [Abstract] [Full Text] [Related]

  • 55. Management of pain and fatigue in the joint hypermobility syndrome (a.k.a. Ehlers-Danlos syndrome, hypermobility type): principles and proposal for a multidisciplinary approach.
    Castori M, Morlino S, Celletti C, Celli M, Morrone A, Colombi M, Camerota F, Grammatico P.
    Am J Med Genet A; 2012 Aug 12; 158A(8):2055-70. PubMed ID: 22786715
    [Abstract] [Full Text] [Related]

  • 56. Measurement of Serum Tenascin-X in Joint Hypermobility Syndrome Patients.
    Yamada K, Watanabe A, Takeshita H, Fujita A, Miyake N, Matsumoto N, Matsumoto KI.
    Biol Pharm Bull; 2019 Aug 12; 42(9):1596-1599. PubMed ID: 31474720
    [Abstract] [Full Text] [Related]

  • 57. The neuromuscular differential diagnosis of joint hypermobility.
    Donkervoort S, Bonnemann CG, Loeys B, Jungbluth H, Voermans NC.
    Am J Med Genet C Semin Med Genet; 2015 Mar 12; 169C(1):23-42. PubMed ID: 25821091
    [Abstract] [Full Text] [Related]

  • 58. Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations.
    Zweers MC, Dean WB, van Kuppevelt TH, Bristow J, Schalkwijk J.
    Clin Genet; 2005 Apr 12; 67(4):330-4. PubMed ID: 15733269
    [Abstract] [Full Text] [Related]

  • 59. The influence of Ehlers-Danlos syndrome - hypermobility type, on motherhood: A phenomenological, hermeneutical study.
    De Baets S, Vanhalst M, Coussens M, Rombaut L, Malfait F, Van Hove G, Calders P, Vanderstraeten G, van de Velde D.
    Res Dev Disabil; 2017 Jan 12; 60():135-144. PubMed ID: 27931013
    [Abstract] [Full Text] [Related]

  • 60. Nationwide population-based cohort study of celiac disease and risk of Ehlers-Danlos syndrome and joint hypermobility syndrome.
    Laszkowska M, Roy A, Lebwohl B, Green PH, Sundelin HE, Ludvigsson JF.
    Dig Liver Dis; 2016 Sep 12; 48(9):1030-4. PubMed ID: 27321543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.